@article{PCM4511,
author = {Claes Wahlestedt and Ines Lohse},
title = {PLX51107, a promising novel bromodomain and extra-terminal inhibitor in chronic lymphoid leukemia treatment},
journal = {Precision Cancer Medicine},
volume = {1},
number = {0},
year = {2018},
keywords = {},
abstract = {Historically hematopoietic malignancies were classified as genetic diseases depending on a small number of driver mutations. Nevertheless, the exact molecular mechanisms driving disease development of malignancies such as chronic lymphoid leukemia (CLL) still remain elusive in most part.},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/4511}
}